PATENT CLAIM ANALYSIS

Application Number: 16090667
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["514", "275000"]

Abstract:
The present invention relates to novel N-[(Pyrimidinylamino)propanyl]- and N-[(Pyridinylamino)propanyl]arylcarboxamide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment or prevention of conditions having an association with the orexin sub-type 1 receptor.

Claim (Index 4):
A pharmaceutical composition comprising a compound according to  claim 1  or a pharmaceutically acceptable salt thereof in admixture with a pharmaceutically acceptable adjuvant, diluent and/or carrier.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 97.0
- Lexical Diversity: 1.26087
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16090325', '16090332', '12600388', '15534200', '13124901']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7589428215515786
- 35 USC 102 Novelty (BERT): 0.4884712551653249
- Combined Prediction Score: 0.7318956649129532
- Mean Citation Score: 216.834006
- Max Citation Score: 278.38632
- Similarity Product: 275.95118041677483

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test